LifeStance Health Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	9.66	-57.44	-186.26	-215.56	-307.2
Depreciation & Amortization	54.75	70.95	80.44	69.2	54.14
Stock-Based Compensation	74.7	76.17	99.39	187.43	259.44
Other Adjustments	47.38	44.95	23.28	28.66	0.9
Change in Receivables	36.09	-6.4	-24.18	-21.66	-24.21
Changes in Accounts Payable	-1.56	0.5	-5.61	7.67	0.62
Changes in Accrued Expenses	19.94	28.61	36.69	13.66	54.85
Changes in Other Operating Activities	-94.81	-50.08	-40.63	-16.6	-29.12
Operating Cash Flow	146.15	107.26	-16.88	52.79	9.42
Operating Cash Flow Growth	36.26%	-	-	460.39%	-
Capital Expenditures	-36.13	-21.57	-40.52	-79.26	-94.49
Payments for Business Acquisitions	-	-	-19.82	-60.21	-99.58
Investing Cash Flow	-36.13	-21.57	-60.34	-139.46	-194.08
Long-Term Debt Issued	-	287.81	57.75	257.32	98.8
Long-Term Debt Repaid	-7.25	-289.49	-2.47	-189.38	-320.21
Net Long-Term Debt Issued (Repaid)	-7.25	-1.69	55.28	67.95	-221.41
Issuance of Common Stock	-	-	-	-	549.91
Net Common Stock Issued (Repurchased)	-	-	-	-	549.91
Other Financing Activities	-8.71	-8.26	-7.86	-20.69	-14.64
Financing Cash Flow	-15.96	-9.95	47.43	47.26	313.86
Net Cash Flow	94.07	75.75	-29.8	-39.41	129.2
Free Cash Flow	110.03	85.69	-57.4	-26.47	-85.07
Free Cash Flow Growth	28.39%	-	-	-	-
FCF Margin	7.72%	6.85%	-5.44%	-3.08%	-12.74%
Free Cash Flow Per Share	0.28	0.23	-0.16	-0.07	-0.26
Levered Free Cash Flow	-55.4	-30.71	-100.61	-152.95	-579.36
Unlevered Free Cash Flow	-38.93	-3.11	-140.16	-200	-278.08

Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q